Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-24-001656
Filing Date
2024-01-08
Accepted
2024-01-08 06:31:44
Documents
102

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm   iXBRL S-1/A 6413631
2 ex5-1.htm EX-5.1 22389
3 ex10-36.htm EX-10.36 63449
4 ex23-1.htm EX-23.1 4289
5 ex23-2.htm EX-23.2 3670
6 ex107.htm EX-FILING FEES 55975
7 ex5-1_001.jpg GRAPHIC 14670
8 ex10-36_001.jpg GRAPHIC 25834
9 forms-1_001.jpg GRAPHIC 4999
10 forms-1_002.jpg GRAPHIC 112921
11 forms-1_007.jpg GRAPHIC 7497
  Complete submission text file 0001493152-24-001656.txt   22807120

Data Files

Seq Description Document Type Size
12 XBRL SCHEMA FILE cldi-20230930.xsd EX-101.SCH 118979
13 XBRL CALCULATION FILE cldi-20230930_cal.xml EX-101.CAL 84451
14 XBRL DEFINITION FILE cldi-20230930_def.xml EX-101.DEF 619493
15 XBRL LABEL FILE cldi-20230930_lab.xml EX-101.LAB 815746
16 XBRL PRESENTATION FILE cldi-20230930_pre.xml EX-101.PRE 684419
95 EXTRACTED XBRL INSTANCE DOCUMENT forms-1a_htm.xml XML 4154511
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

EIN.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-274885 | Film No.: 24518228
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)